View in EDS

The Evolution of SEND at AstraZeneca.

Saved in:
Bibliographic Details
Title: The Evolution of SEND at AstraZeneca.
Authors: Kent C; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Coupland B; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Barnard C; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Alderley Park, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Schofield J; Data Science & AI, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: SEND-Data-Management@astrazeneca.com., Afif-Rider S; Regulatory Safety, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, USA. Electronic address: SEND-Data-Management@astrazeneca.com.
Source: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2021 Jul; Vol. 123, pp. 104954. Date of Electronic Publication: 2021 May 08.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0295 (Electronic) Linking ISSN: 02732300 NLM ISO Abbreviation: Regul Toxicol Pharmacol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1096-0295
DOI:10.1016/j.yrtph.2021.104954